105 related articles for article (PubMed ID: 27785926)
1. Imaging on nodal staging of prostate cancer.
Kilcoyne A; Price MC; McDermott S; Harisinghani MG
Future Oncol; 2017 Mar; 13(6):551-565. PubMed ID: 27785926
[TBL] [Abstract][Full Text] [Related]
2. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
3. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
[TBL] [Abstract][Full Text] [Related]
4. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
Schumacher MC; Radecka E; Hellström M; Jacobsson H; Sundin A
Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948
[TBL] [Abstract][Full Text] [Related]
5. Lymph node staging in prostate cancer.
Sankineni S; Brown AM; Fascelli M; Law YM; Pinto PA; Choyke PL; Turkbey B
Curr Urol Rep; 2015 May; 16(5):30. PubMed ID: 25773350
[TBL] [Abstract][Full Text] [Related]
6. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.
van der Poel HG; Buckle T; Brouwer OR; Valdés Olmos RA; van Leeuwen FW
Eur Urol; 2011 Oct; 60(4):826-33. PubMed ID: 21458154
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
[TBL] [Abstract][Full Text] [Related]
9. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
Giannarini G; Petralia G; Thoeny HC
Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
[TBL] [Abstract][Full Text] [Related]
10. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
Harisinghani MG; Barentsz J; Hahn PF; Deserno WM; Tabatabaei S; van de Kaa CH; de la Rosette J; Weissleder R
N Engl J Med; 2003 Jun; 348(25):2491-9. PubMed ID: 12815134
[TBL] [Abstract][Full Text] [Related]
12. [Radioisotope lymphoscintigraphy used for precise diagnosis of metastatic lymph node involvement in localized and locally advanced prostate cancer].
Rusakov IG; Alekseev BIa; Niushko KM; Frank GA; Belova EA; Bespalov PD; Vorob'ëv NV; Poliakov VA
Vopr Onkol; 2006; 52(6):686-90. PubMed ID: 17338250
[No Abstract] [Full Text] [Related]
13. Lymph nodal metastases: diagnosis and treatment.
Di Muzio N; Fodor A; Berardi G; Mapelli P; Gianolli L; Messa C; Picchio M
Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):421-9. PubMed ID: 23069921
[TBL] [Abstract][Full Text] [Related]
14. Imaging prostate cancer lymph node metastases with a multimodality contrast agent.
Hall MA; Kwon S; Robinson H; Lachance PA; Azhdarinia A; Ranganathan R; Price RE; Chan W; Sevick-Muraca EM
Prostate; 2012 Feb; 72(2):129-46. PubMed ID: 21538422
[TBL] [Abstract][Full Text] [Related]
15. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
16. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
[TBL] [Abstract][Full Text] [Related]
17. Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement.
Van den Bergh L; Joniau S; Haustermans K; Deroose CM; Isebaert S; Oyen R; Mottaghy FM; Ameye F; Berkers J; Van Poppel H; Lerut E
Acta Oncol; 2015 Jun; 54(6):896-902. PubMed ID: 25591936
[TBL] [Abstract][Full Text] [Related]
18. Advances in sentinel node dissection in prostate cancer from a technical perspective.
Acar C; Kleinjan GH; van den Berg NS; Wit EM; van Leeuwen FW; van der Poel HG
Int J Urol; 2015 Oct; 22(10):898-909. PubMed ID: 26173593
[TBL] [Abstract][Full Text] [Related]
19. FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy.
Jeong IG; Hong S; You D; Hong JH; Ahn H; Kim CS
Ann Surg Oncol; 2015 Sep; 22(9):3150-6. PubMed ID: 25634779
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT.
Borley N; Fabrin K; Sriprasad S; Mondaini N; Thompson P; Muir G; Poulsen J
Scand J Urol Nephrol; 2003; 37(5):382-6. PubMed ID: 14594685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
